Compare Cigna Corp (CI) vs Morgan Stanley (MS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Morgan Stanley — how do they compare? Cigna Corp trades at $300.3 (market cap $80.25B), while Morgan Stanley trades at $223.75 (market cap $359.10B). The key difference: Morgan Stanley is far larger — about 4.5× Cigna Corp's market cap, and Cigna Corp pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| CI | MS | |
|---|---|---|
Market Cap | $80.25B | $359.10B |
Sector | Health | Financials |
52-Week High | $311.00 | $228.17 |
52-Week Low | $244.41 | $139.09 |
Enterprise Value | $103.35B | — |
Dividend Yield | 2.06% | 1.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
Morgan Stanley (MS) trades at $221.09, down 0.54% on the day, with a bullish technical signal from moving averages and strong fundamental performance including three consecutive quarterly earnings beats. Revenue grew to $66.0B in 2025 with net income margin expanding to 25.56%, while analyst consensus remains positive with a $225.80 price target. Recent news highlights the firm's role in leading Anthropic's upcoming IPO and expanding AI integration in wealth management.
The outlook for MS is favorable given earnings momentum and strategic positioning in high-growth areas like AI and IPO advisory, though risks include volatile cash flows and high debt levels. The stock presents a potential 2.1% upside to the consensus target, supported by 53.85% analyst buy ratings, but investors should monitor interest expense and macroeconomic impacts on financial services.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →
